We came across a bullish thesis on GRAIL, Inc. on Value investing subreddit by BombasticBillionaire. In this article, we will summarize the bulls’ thesis on GRAL. GRAIL, Inc.’s share was trading at $86.41 as of October 16th.
Grail (GRAL) is emerging as a leader in multi-cancer early detection (MCED) with its Galleri blood test, which leverages machine learning on DNA methylation patterns to detect signals from over 50 cancer types, including hard-to-screen cancers like...
